title: Managing elderly people's osteoporosis. Why? Who? How?
abstract: OBJECTIVE
  To guide family physicians through assessment of why treating elderly people's osteoporosis is necessary, who to treat, and how to treat in a practical way.
  
  
  METHODS
  Evidence of the efficacy of treatment for osteoporosis is shown by a reduced probability of fracture. This can be ascertained by direct evaluation for bisphosphonates, calcium, and calcitonin, or indirectly by ascertaining benefit to bone mineral density for hormone replacement therapy (HRT) and exercise.
  
  
  RESULTS
  Unless medically contraindicated, all elderly people should take supplementary vitamin D (800 IU/d) and calcium (1500 mg/d). Those with risk factors for osteoporosis (e.g., smoking, thinness, previous fracture when older than 50 years, fracture in first-degree relatives older than 50 years, and steroid use) should have a bone density measurement. Those meeting World Health Organization criteria for osteoporosis should also be treated with HRT or bisphosphonates or possibly with selective estrogen receptor modulators.
  
  
  CONCLUSIONS
  Good evidence indicates that adequate treatment of osteoporosis can prevent fractures and thus reduce associated morbidity and mortality among vulnerable elderly people. Because of the prevalence of osteoporosis, the onus falls on family physicians to be the front-line managers.
authors.affiliation: Department of Medicine, University of Alberta, Edmonton. ajuby@cha.ab.ca
authors.forename: A
authors.initials: A
authors.lastname: Juby
mesh_terms: D000368:Aged; D015519:Bone Density; D002118:Calcium / Q000627:therapeutic use; D019587:Dietary Supplements; D005081:Exercise Therapy; D005194:Family Practice; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D016330:Frail Elderly; D020249:Hormone Replacement Therapy; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000150:complications / Q000628:therapy*; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000628:therapy; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D014807:Vitamin D / Q000627:therapeutic use
chemical_list: D014807:Vitamin D; D002118:Calcium